Ukuba uhlala kunye nokutshisa okutshisa , uyazi ukuba uvakalelo aluyinto enhle njengoko unakho wakufanekisa. Omnye umfazi ochaza ukutshisa okushisayo ngokuthi "ukuba nekhefu lakhe langasese" kufuneka alityale malunga neenqwaba zokuhlamba ezihamba nale mijelo. Nangona kunjalo sifunda ukuba ukutshisa okushisayo akusoloko kubi. Enyanisweni, ingaba isiliva sesilivere, ukuxela ukuba unyango lwakho lomhlaza webele lusebenza okanye ukuba usemngciphekweni ophantsi kunokuba ubungenako ukutshisa okutshisa ngala mayeza.
Izifundo zisitsho ukuba "isiganeko esibi" sitshisa kakhulu-ngokukodwa xa sinobukhulu kwaye senzeke ngokuphindaphindiweyo-kuqikelele ukusinda okukhulu kubantu abaphathwa ngonyango lwe- hormone yomhlaza wesifuba njenge-tamoxifen okanye i-aromatase inhibitor exemestane. Kwaye abo abangazange banomdlavuza wesibeleko kodwa bajamelana nokutshisa okutshisayo, ezi zihlandlo zokutshiza (okanye ukucoca) zingabonakalisa uphawu oluhle.
Makhe sijonge oko sikufundayo malunga nokutshisa okutshisa kunye nezinye iziganeko ezichaseneyo ezinxulumene nophando lomhlaza webele, nendlela ongayisebenzisa ngayo le ngcaciso ngendlela enokukunceda xa uhlangabezana nale miba emibi.
I-Estrogen, i-Hot Flashes, kunye neCanscer Breast
Ngendlela, kunengqiqo ukuba ukutshisa okutshisayo kunokunxibelelana nomngcipheko omncinci wesibeleko sebele okanye ukuphindaphinda umdlavuza webele. Siyazi ngokucacileyo ukuba i- estrogen idlala indima emdlalweni wesifuba kunye nokutshisa okutshisa ngokuqhelekileyo xa ii-ovari ziyeka ukuvelisa i-estrogen ngexesha lokuphela kwesisu.
Ngomdlavuza webele, i-estrogen yenza into encinci njenge-jet fuel, ngokukhawuleza ukukhula kwee -cancer zesisu se-receptor-positive . Xa i-estrogen ivaliwe (okanye ukuba i-androgens emva kokumiswa komzimba ayigunyaziwe ukuba iguqulwe ibe yi-estrogen), iiseli zomhlaza zesifuba ziphelelwa yi-gas.
Amachiza e-hormone asetyenziselwa isifo somhlaza wesifuba avame ukubangela ukutshisa okutshisa, kodwa ukutshisa okutshisayo akufani omnye umntu.
Abanye abantu baxakeka kakhulu ngenxa yokutshisa okutshisa kunye nobusuku bobusuku, ngelixa abanye bafumana ubuncinci okanye akukho nanye "kule mpendulo. Ngokwazi oku, kunengqiqo ukuba abaphandi banomdla ekufumaneni ukuba ngaba besetyhini abatshisa kakhulu (kubhekiswa ngamagqirha njenge " iimpawu ze-vasomotor ") baphendule bhetele kule zonyango.
Ukutshisa okushisayo, unyango lwe-Cancer, kunye nokuPhila
Ucwaningo oluninzi phakathi kuka-2012 no-2016 lubone ukuba ukutshisa kushushu kungabonakalisa ukuba umntu uya kuphendula ngokubhetele kwiinyango ezithile ze-hormonal, kunye nokuba ngaba besetyhini abavuthayo ngokugqithiseleyo banokuthi bavelise umdlavuza webele.
Nangona sisazi ukuba ukutshisa okutshisayo kudibene nokuhla kwe-estrogen emzimbeni, asiyazi kakuhle nokuba kutheni kwenzeka. Ngamanye amagama, asiqinisekanga ukuba amazinga ase-estrojeni aphantsi afaka isandla ekutshiseni kokutshisa kunye nokukhula komhlaza wesifuba, okanye ukuba kukho nezinye iindlela eziphantsi kweenkqubo zombini.
IHormone Ukwelashwa kwe-Estrogen Receptor I-Cancer Breast Cancer
Ngaphambi kokuba sixoxe ngexabiso elichazayo lokutshisa okutshisayo kunye neziyobisi zesifo somhlaza webele, kunceda ukuthetha ngokufutshane izidakamizwa esizithethayo, ezo zithathwa njengonyango lwe-hormone (okanye unyango lwe-endocrine) lomhlaza wesifuba.
Ngokulula, kukho ezimbini iintlobo eziphambili zonyango ze-hormone ezisetyenziselwa ukwelapha umdlavuza webele we-estrogen.
- I-modermator receptor (SERMs) ekhethiweyo njenge- tamoxifen -Tamoxifen isebenza ngokuthintela ubuchule be-estrogen ukuba ibophe kunye neeseli zomhlaza zesisu kwaye ibangele zikhule. Kubabhinqa be-premenopausal, ii-ovari ziqhubeka zenza i-estrogen kunye nesilwanyana ezifana ne-tamoxifen iyadingeka.
- I-Aromatase inhibitors (AI) - I-AI yiziyobisi ezisetyenziselwa ngabafazi be-postmenopausal (okanye abafazi be-premenopausal abaye baphathwa ngonyango lokunyanzelisa i-ovarian okanye bachithe ama-ovari abo) ukukhusela ukuhlanganiswa kwe-estrogen emzimbeni. Benza oku ngokuthintela ukuguqulwa kwe-androgens kwi-estrogens, impendulo eyenziwa ngama-enzyme abizwa ngokuthi i-aromatase. Izidakamizwa ezikhethwe njenge- aromatase inihbitors ziquka i-Arimidex (i-anastrozole), i-Aromasin (i-exemestane) ne-Femara (i-letrozole).
Exemestane, Hot Flashes, kunye neMpendulo Yonyango Ngomhlaza Webele
Uphando olwenziweyo ngo-2012 olujonge abafazi abathatha i-exemestane bafumanisa ukuba abo babefudumezelayo ngexesha lotyando babenomlinganiselo okhulayo wokuhlaselwa kwamahhala. Olunye uphando ngo-2016 olujongene nabafazi be-postmenopausal bephathwa nge-exemestane bafumana iziphumo ezifanayo. Abasetyhini abaneempembelelo ezivuthayo (ukutshisa okutshisayo kunye nobusuku bobusuku) bebanokuthi baphendule kwiinkqubo zonyango ngaphandle kwalabo abangenazo iimpawu (iipesenti ezingama-70 ezimalunga nama-40 ekhulwini.) Ngokwahlukileyo, akukho mmahluko kwizinga lokuphendula iziyobisi phakathi kwalabo abenza okanye abangazange babe neentsimbi zomzimba okanye iintlungu zomzimba. Kule sifundo, impendulo kwi-exemestane ichazwe njengepesenti ezingama-30 okanye ukunciphisa okukhulu kwimizimba yesisu kwizifundo zengcamango.
I-Tamoxifen (okanye i-Exemestane), i-Hot Flashes, ne-Survival Brever Cancer
Uvavanyo lwango-2013 lubhekisele kuma-9 000 amabhinqa awaphathwa nge-tamoxifen okanye i-exemestane. Abo babefudumezelayo babesenokuba nokuphila okungenampilo (ngeepesenti ezingama-27), ukusinda ngokubanzi (45 ekhulwini kwipesenti) kunye neendlela ezikude eziqhelekileyo (ama-19 ekhulwini anethuba elingaphantsi lokuba izibeleko zabo zazisasazeka kwizitho ezikude ezifana nobuchopho, imiphunga, isibindi , okanye amathambo.)
Kulolu cwaningo (ngokungafani nesifundo esasentla), abafazi ababenemisipha kunye namaqabane ahlangeneyo, kunye nalabo babenempawu ezikhuselekileyo banokuphila kunabasetyhini abangenayo le mpawu.
Ukutshisa okutshisa kunye neengozi yokuphucula umdlavuza webele
Nangona kunengqiqo ngendlela abantu abavuthayo abaya kubakho ukuba banomdla wokuvelisa umdlavuza webele; kwakungekho kude kube kutshanje ukuba uphando lufumene ukuba oluyinyaniso.
Uphando olwenziwe ngo-2011 lufumanise ukuba abafazi ababetshisa ukutshisa babesisigxina nje ukuba bakwazi ukuvelisa umdlavuza webele kunabasetyhini abangazange bafumane ukutshisa okutshisa. Abasetyhini abanezibhokozo ezitshisayo babengama-50 ekhulwini abangaphantsi kwamathuba okuhlakulela i-ductal carcinoma yebele kwaye i-50 ekhulwini yayingaphantsi kokuhlakulela i-lobular carcinoma engavumelekanga . Ukongezelela, kwafunyaniswa ukuba ukutshisa okutshatyalaliswa ngokuphindaphindiweyo, kunye nokugqithisa ngakumbi, ukunciphisa kakhulu umngcipheko wesifo somhlaza.
Kanti esinye isifundo esisodwa ngo-2013 safumanisa ukuba abafazi abaye bafumana ukutshisa okutshisayo (kunye nezinye iimpawu zesifo se-menopausal) babenomyinge wengozi wokuphucula umdlavuza webele omtsha (ochazwe njengomhlaza wesifuba ngaphambi kokuba uneminyaka engama-50) kunabesifazana abangazange bafumane ezi iimpawu.
Ikhonkco Phakathi Kokukhanya Okushisayo kunye neCanscer Breast
Nangona zonke ezi zifundo zifumene unxibelelwano phakathi kokutshisa okutshisayo kunye nokuphendula okungcono kwimiphumo ye-hormones yomhlaza wesibeleko (okanye umngcipheko omncinci wokuvelisa umdlavuza webele) asikaqinisekanga ngokuchanekileyo ukuba ezi zinto zidibene njani okanye ukuba kwenzeka njani.
Ukunceda Ukutshisa Okushisayo
Ukutshisa okutshisayo akuyonwabi kwaye abazenzi nto ekuphuculeni umgangatho wobomi kubasetyhini abaninzi abahlala nomhlaza wesibele. Ngombulelo, uphando lubhekisele kwiindlela zokuphucula le mpawu (ngelixa uphepha u-estrogen.)
Ilizwi lokulumkisa lenzelwe ukuba abo baqwalasela ezinye iindlela zokwelapha ezifana nokulungiswa kwamanzi ukuze bakwazi ukujamelana nokutshisa okutshisa. Ezinye izongezo ezifana ne-soy iqukethe "i- phytoestrogens ," i-estrogens esekelwe kwisityalo kunye neendawo ezinjenge-estrogen. Ekubeni i-estrogen isetyenziswe njengamafutha esifo somhlaza wesisu kubantu abanesifo se-estrogen esithobileyo, iinqununu ezininzi zincoma ukuba zihlale zicacile kwi-supplementary soy-based based until we know more.
I-Exexor yinto echasayo yinto enokubangela ukutshisa okutshisayo kwabanye abesifazana, kwaye ngokungafani nezinye izidandlululo, ayibonakali ukuba inxibelelwano efanayo kunye ne-tamoxifen. I-Neurontin (gabapentin) yinyango yokuthumba enganceda ukunciphisa ukutshisa okutshisa. Kuqhelekileyo kusetyenziswa ukunyanga i-neuropathy kunye neentlungu ezibangelwa yintsholongwane eyenziwa ngabantu abathile kwi-chemotherapy yomhlaza webele.
Ngelixa i-vitamin E ifunyenwe ngabanye, uhlobo lwe-vitamin E lubaluleke kakhulu, njengoko ezinye iindidi ze-vitamin E ziyakususa izibonelelo ze-chemotherapy. Ngokwahlukileyo, enye ifomu ebizwa ngokuba yi-tocotrienols inokubangela ukuba i-tamoxifen ibe nempembelelo kwi-cell cancer eselgen receptor-positive cells.
Ngaphambi kokuqwalasela nayiphi na isongezelelo, qiniseka ukuthetha nodokotela wakho. Siyazi ukuba kukho ukulungiselela amavithamini kunye nezamaminerali ezingabaphazamisa unyango lomhlaza .
Abanye abantu baye bafumanisa ukuba i- acupuncture ibe luncedo ngokutshisa okutshisa, kodwa kwakhona, xela ugqirha wakho. Ezinye zeendlela ezifanelekileyo zokulawula ukutshisa okutshisa zilula. Hlola ezi ndlela ezili-10 zokujamelana nokutshisa okutshisayo nomhlaza wesifuba .
ILizwi
Umgca ophantsi wezifundo ezijonga ukutshisa okutshisayo ngexesha lokunyangwa kwengculaza yebele (ubuncinane unyango kunye nemishanguzo ye-hormone) kukuba ezi zivuthayo ezinokutshisa zinokuba ne-silver lining. Ukukwazi oku akuyi kubangela ukutshisa kwakho okutshisa ngakumbi, kodwa le nto ingaba yindlela yokusebenzisa ukurhoxisa ukukunceda.
Ukurhoxisa yinkqubo apho ukhangeleka ngokukodwa imeko kwiimeko ezahlukeneyo. Ngokomzekelo, endaweni yokugxininisa kweenwele zakho ngexesha le-chemotherapy kwaye oko kukukwenza uzive njani, mhlawumbi ufumane isilivere-ungayifuni imbobo yakho imilenze inyanga. Ngokuqinisekileyo, oko kusalula kancane, kodwa ngexesha elilandelayo unesitshisi esishisayo unokufuna ukutshintshisa ukutshisa okutshisayo ngaphandle kweeseli zomhlaza zesisu ezingase zihlale emzimbeni wakho. Ngaloo ndlela, ubuncinci "ihlobo lakho langasese" linesilivere esiliva.
> Imithombo:
> Desai, K., Mao, J., Su, I., Demichele, A., Li, Z., Xie, S., kunye noP. Gehrman. Ubuninzi kunye neengozi ze-insomnia Phakathi kwezigulane ze-Breast Cancer kwi-Aromatase Inhibitors. Unonophelo loNcedo kwiCancer . 2013. 21 (1): 43-51.
> Fei, C., DeRoo, L., Sandler, D., kunye no-C. Weinberg. Iimpawu zeMenopausal kunye neengozi yeCancer-Onset Breast Cancer. I-European Journal yeCarcer . 2013. 49 (4): 798-804.
> Fontein, D., Charehbili, A., Nortier, J. et al. Iziganeko eziMbi ziNxulumene neMpendulo kwi-Exemastane Treatment kwi-Postmenopausal Breast Cancer Iziguli: Iziphumo ezivela kwi-TEAMIA Study (BOOG2006-04). I-European Journal ye-Oncology yokugulisa . 2016 Dec 10.
> Fontein, D., Houtsma, D., Hille, E. et al. Ubudlelwane phakathi kweziganeko ezimbi kunye noPhulo lwe-Exemastane unyango kwi-Early Postoperative Breast Canopus Breast Cancer. Amanqaku e-Oncology . 2012. 23 (12): 3091-7.
> Fontein, D., Seynaeve, C., Hadji, P. et al. Iziganeko ezimbi ezichazayo Ukuqikelela ukuphunyulwa kwezigulane kwizigulane ezithatyathwa ngeTamoxifen okanye i-Aromatase Inhibitors: Uhlalutyo lwe-Tamoxifen Exemestane International Adjuvant Trial Analysis. Umbhalo we-Clinical Oncology . 2013. 31 (18): 2257-64.
> Huang, Y., Malone, K., Cushing-Haugen, K., Daling, J., kunye noC. Ubudlelwane phakathi kweMpawu zeMenopausal kunye nobungozi beCanseropausal Breast Cancer. I-Epidemiology ye-Cancer Biomarkers kunye nokukhusela . 2011. 20 (2): 379-88.